Latest Breaking News On - Meeting of the american society hematology - Page 1 : comparemela.com

GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia

/PRNewswire/ GenFleet Therapeutics, a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, announced that U.S..

Yu wangUnited statesHong kongSellas life sciencesLife sciences group nasdaqDrug administrationMeeting of the american society hematologyGenfleet therapeuticsChief medical officerTrack designationAccelerated approvalPriority reviewAmerican societySciences groupGreater china

JNJ multiple myeloma therapy outperforms standard of care (NYSE:JNJ)

JNJ multiple myeloma therapy outperforms standard of care (NYSE:JNJ)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesBristol myers squibbDarzalex fasproMeeting of the american society hematologyAnnual meetingAmerican society

Keros stock falls after mid-stage data for blood cancer drug

Keros stock falls after mid-stage data for blood cancer drug
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesMeeting of the american society hematologyAnnual meetingAmerican society

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-1

BE-101 is Company’s Lead Program in Hemophilia B; IND Filing Anticipated in Mid-2024Be Bio Appoints Glenn Pierce, M.D., Ph.D., Hemophilia Physician-Researcher and Advocate, to its Scientific Advisory BoardPreclinical Study Findings Shared in Oral Presentation During 65th Annual Meeting of the American Society of Hem.

San diegoUnited statesRicharda morganDavid rawlingsRichard jamesJoanne smith farrellBristol myers squibbUs department of healthHemophiliab national bleeding disorders foundationDrug administrationLongwood fundHuman servicesSeattle children research instituteAmerican society of hematologyUs centers for diseaseBlood products advisory committee

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoRicharda morganRichard jamesJoanne smith farrellDavid rawlingsRichard morganUs centers for diseaseBlood products advisory committeeBristol myers squibbOral presentation at american society of hematologySeattle children research instituteAmerican society of hematologyHemophiliab national bleeding disorders foundationAtlas ventureDrug administration